NACG brings together key stakeholders in clinical genomics across the Nordic countries, including representatives from clinical, research, industry and governmental organisations, with the common goal of advancing the clinical implementation of genomics.

Organisations and individuals are welcome to apply for NACG membership by submitting collaboration agreement / license agreement (see Resources) to post@nordicclinicalgenomics.org.

Founding partners

Copenhagen University Hospital (Rigshospitalet)
Center for Genomic Medicine
Denmark

Copenhagen University Hospital (Rigshospitalet)
Department of Clinical Genetics
Denmark

DNV GL AS

Karolinska Institutet
Department of Microbiobiology, Tumor and Cell Biology (MTC)
Sweden

Karolinska Universitetssjukhuset
Centre for Inherited Metabolic Diseases (CMMS)
Sweden

Karolinska Universitetssjukhuset
Clinical Genetics
Sweden

Landspitali - The National University Hospital of Iceland
Department of Genetics and Molecular Medicine
Iceland

National Genomics Initiative
SciLifeLab
Sweden

Norwegian Consortium for Sequencing and Personalized Medicine
NorSeq
Norway

Oslo University Hospital
Department of Medical Genetics
Norway

SciLifeLab
Clinical Genomics Stockholm facility
Sweden

Host institutions

Karolinska Institutet
Department of Microbiobiology, Tumor and Cell Biology (MTC)
Sweden

Copenhagen University Hospital (Rigshospitalet)
Department of Clinical Genetics
Denmark

Copenhagen University Hospital (Rigshospitalet)
Center for Genomic Medicine
Denmark

Oslo University Hospital
Department of Medical Genetics
Norway

Organisational members

Organisations and individuals are welcome to apply for NACG membership by submitting collaboration agreement / license agreement (see Resources) to to post@nordicclinicalgenomics.org.​ 

Aalborg University Hospital
Molecular Diagnostics
Denmark

St. Olavs Hospital
Section for genetic laboratory services
Norway

University of Helsinki
FIMM (Institute for Molecular Medicine)
Finland

Danish National Genome Center
Denmark

Helsinki University Hospital, HUS Diagnostic Center
Genetics
Finland

Aarhus University Hospital
Department of Molecular Medicine (MOMA)
Denmark

Copenhagen Institute for Futures Studies (CIFS)
Denmark

iCellate Medical AB

Sweden

Nordic Permed Law
Oslo
Norway

Nordic Permed Law (NPL)

NACG is collaborating closely with the Nordic Permed Law (NPL) network, established May 27th 2020. NPL contact person: Gjertrud Bøhn Mageli.

This close collaboration creates a unique meeting place for discussing challenges in the intersection between technology and legal frameworks, and for co-creating solutions to overcome barriers. 

NPL objectives

The objectives of Nordic Permed Law are:

(1) To establish cooperation among the Nordic countries with respect to legal issues and jurisprudential research on personalised medicine, as well as medicine, technology and health.

(2) To discuss and harmonise legal perspectives and establish a foundation for common regulatory development in the Nordic countries.

(3) To use the organisation as a competency centre and bridge builder between legal, medical and technological professional communities, and to be a preferred partner for research and development.

(4) To assist in communication and debates on questions of values and legal issues in certain legal areas.

Collaboration

Aligned with NACG goals and activities, we are collaborating closely with leading organisations to advance clinical genomics.

Global Alliance for Genomics & Health (GA4GH)
The Global Alliance for Genomics and Health (GA4GH) is a policy-framing and technical standards-setting organization, seeking to enable responsible genomic data sharing within a human rights framework.

Genomics in Health Implementation Forum
The Genomics in Health Implementation Forum (GHIF) aims to empower knowledge exchange and collaboration among global initiatives as they pursue the common goal of advancing human health.